i-GONAD: a robust method for in situ germline genome engineering using CRISPR nucleases
2018
Ohtsuka, Masato | Satō, Masahiro | Miura, Hiromi | Takabayashi, Shuji | Matsuyama, Makoto | Koyano, Takayuki | Arifin, Naomi | Nakamura, Shingo | Wada, Kenta | Gurumurthy, Channabasavaiah B.
We present a robust method called improved-Genome editing via Oviductal Nucleic Acids Delivery (i-GONAD) that delivers CRISPR ribonucleoproteins to E0.7 embryos via in situ electroporation. The method generates mouse models containing single-base changes, kilobase-sized deletions, and knock-ins. The efficiency of i-GONAD is comparable to that of traditional microinjection methods, which rely on ex vivo handling of zygotes and require recipient animals for embryo transfer. In contrast, i-GONAD avoids these technically difficult steps, and it can be performed at any laboratory with simple equipment and technical expertise. Further, i-GONAD-treated females retain reproductive function, suggesting future use of the method for germline gene therapy.
Afficher plus [+] Moins [-]Mots clés AGROVOC
Informations bibliographiques
Cette notice bibliographique a été fournie par National Agricultural Library
Découvrez la collection de ce fournisseur de données dans AGRIS